Date:
Tuesday, April 2, 2019, 8:30am to 7:00pm
Location:
Norton's Woods Conference Center
Harvard-MIT CRS Regulatory Science Symposium 2019
April 2nd, 8:30 AM - 7 PM
Norton's Woods Conference Center
Register Here!
About the event:
The Harvard-MIT CRS Regulatory Science Symposium is a scientific meeting open to the entire community that aims to promote open, multi-stakeholder dialogue about important regulatory science challenges and advances. In addition to members of the Center, this symposium welcomes broader participation from academia, regulatory agencies, industry, and patient advocates.
Our featured speakers include the keynote Richard Platt (PI of the FDA Sentinel Program) as well as researchers and practitioners from the FDA, academia, and industry.
Please contact Helen Yang (helen@hms.harvard.edu) for more information.
April 2nd, 8:30 AM - 7 PM
Norton's Woods Conference Center
The Harvard-MIT Center for Regulatory Science is holding its annual symposium on Tuesday, April 2, 2019. In addition to scientific talks and panel discussions, there will be a poster session open for graduate students and fellows to present their research. We encourage students to join us to hear from diverse fields including economics, bioethics, healthcare policy, public policy, drug/device regulatory policy, pharmaceutical R&D, patent law, biomedical research, and more.
There will be light refreshments and an open bar during the poster sessionRegister Here!
About the event:
The Harvard-MIT CRS Regulatory Science Symposium is a scientific meeting open to the entire community that aims to promote open, multi-stakeholder dialogue about important regulatory science challenges and advances. In addition to members of the Center, this symposium welcomes broader participation from academia, regulatory agencies, industry, and patient advocates.
Our featured speakers include the keynote Richard Platt (PI of the FDA Sentinel Program) as well as researchers and practitioners from the FDA, academia, and industry.
This year’s featured topics include:
- Real-World Evidence
- Digital Health
- Advances in International Clinical Trials
- Complex Generics
- Drug Repurposing for Unmet Needs
- Regulatory Frameworks
- More information can be found here.
Please contact Helen Yang (helen@hms.harvard.edu) for more information.